MZTI NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

The Marzetti Company · Consumer Defensive · Packaged Foods

Open interactive chart View report data
Latest close 106.9 USD
-0.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -19.9% below the Trend Line and sits at 3.2% of its 52-week range. The latest completed week returned -0.3%, after a -7.7% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 58/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 18d.

Setup score 24 out of 100
Latest Close 106.9 USD 31 Jul 2026
1W Return -0.3% latest completed week
4W Return -7.7% short-term follow-through
12W Return -5.1% quarterly tape
Trend Breadth 3.8% 2 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.3% Latest completed week; four-week move -7.7%. Indicator stack 2/53 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 58/100 conviction; expected move 8.3%. News sentiment 53/100 44 relevant articles in the latest sentiment read. Event risk 18d Next report is scheduled for 20 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -19.9% below the Trend Line and sits at 3.2% of its 52-week range. The latest completed week returned -0.3%, after a -7.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0912-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.7% over four weeks, -5.1% over 12 weeks, and -37.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.3%
4W-7.7%
12W-5.1%
26W-36.7%
52W-37.9%
Active trend streak0 weeks
Active weeks in one year2
Trend breadth3.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.20Latest activity-pressure read.
Pressure change77.1%Four-week change in activity pressure.
Leadership-34.87Latest relative-leadership reading.
RS change0.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength77/100Blend of value, momentum, and quality. Underlying universe rank 24; rank 1 is best.
Value80/100Relative valuation strength. Underlying universe rank 21; rank 1 is best.
Quality82/100Profitability and accounting quality. Underlying universe rank 19; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth14/100Revenue and earnings growth. Underlying universe rank 87; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework72/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
16.7x
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
9.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
14.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
24.2%
Gross profit retained from each unit of revenue.
Operating margin
11.8%
Operating profit retained from revenue.
Free-cash-flow margin
19.9%
Free cash flow generated from revenue.
Return on invested capital
20.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.8%
Latest one-year revenue growth.
EPS growth
3.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
37.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.7%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
4.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

MZTI shows bearish options pressure with a 58/100 conviction score, put-call volume ratio of n/a, expected move of 8.3%, and Sharemaestro trend signal inactive.

Conviction58/100
Expected move8.3%
Put/call volume
Pressure-96
Speculation4
Volatility57
Trend agreement42
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 44 relevant articles.

11 positive · 28 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings18dNext report is scheduled for 20 Aug 2026; event risk rises as the date approaches.
Options expected move8.3%Nearest-chain priced movement where available.
52-week drawdown-42.5%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+8.3%Week of 26 Jun.
Worst week-9.8%Week of 6 Feb.
Latest week-0.3%Week of 31 Jul.

Shape of recent returns

Strong gains1
Modest gains8
Flat weeks0
Modest losses9
Sharp losses8
Recent vol4.2%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis10/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.09; No reversal markers Factors63/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 38; Small Cap Core rank 29 SVQF72/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 204.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options33/100

MZTI shows bearish options pressure with a 58/100 conviction score, put-call volume ratio of n/a, expected move of 8.3%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 8.3% Sentiment53/100

Weighted news tone is neutral across 44 relevant articles.

The Marzetti Company (MZTI): Buy, Sell, or Hold Post Q1 Earnings? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings18d

Next report is scheduled for 20 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026106.9 USD-0.3%133.4 USD164.2 USD-0.20-34.871.6MOff
24 Jul 2026107.2 USD0.0%135.3 USD164.7 USD-0.31-35.131.3MOff
17 Jul 2026107.1 USD-6.7%137.1 USD165.2 USD-0.28-36.981.6MOff
10 Jul 2026114.8 USD-0.9%139.1 USD165.6 USD-0.54-36.071.1MOff
3 Jul 2026115.8 USD-0.1%140.8 USD166.0 USD-0.87-35.111.2MOff
26 Jun 2026115.9 USD8.3%142.2 USD166.4 USD-1.13-35.242.3MOff
19 Jun 2026107.1 USD-4.1%143.7 USD166.9 USD-1.45-43.492.0MOff
12 Jun 2026111.6 USD4.0%145.8 USD167.4 USD-1.47-40.271.4MOff
5 Jun 2026107.4 USD-3.2%147.6 USD167.8 USD-1.39-41.891.8MOff
29 May 2026110.9 USD-2.7%149.7 USD168.3 USD-1.33-43.331.7MOff
22 May 2026113.9 USD0.9%151.1 USD168.8 USD-1.28-40.801.7MOff
15 May 2026113.0 USD0.3%152.7 USD169.3 USD-1.24-41.241.7MOff
8 May 2026112.6 USD-8.6%154.5 USD169.8 USD-1.17-42.242.6MOff
1 May 2026123.2 USD-2.4%156.1 USD170.3 USD-1.14-34.131.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.